108 related articles for article (PubMed ID: 11797843)
1. Inhibition of cell proliferation and antitumor activity of a novel organotin compound.
Syng-Ai C; Basu Baul TS; Chatterjee A
J Environ Pathol Toxicol Oncol; 2001; 20(4):333-42. PubMed ID: 11797843
[TBL] [Abstract][Full Text] [Related]
2. Cell proliferation inhibition and antitumor activity of novel alkyl series of diorganotin(IV) compounds.
Koch B; Baul TS; Chatterjee A
J Appl Toxicol; 2008 May; 28(4):430-8. PubMed ID: 17668440
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative and cytotoxic effect of a novel organotin compound on mammalian cells both in vitro and in vivo.
Syng-ai C; Basu Baul TS; Chatterjee A
Mutat Res; 2002 Jan; 513(1-2):49-59. PubMed ID: 11719089
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of dimethyl tin 4-cyclohexyl thiosemicarbazone as a novel antitumor agent.
Sen A; Chaudhuri TK
Exp Oncol; 2009 Mar; 31(1):22-6. PubMed ID: 19300412
[TBL] [Abstract][Full Text] [Related]
5. p53-dependent antiproliferative and antitumor effect of novel alkyl series of diorganotin(IV) compounds.
Koch B; Basu Baul TS; Chatterjee A
Invest New Drugs; 2009 Aug; 27(4):319-26. PubMed ID: 18802665
[TBL] [Abstract][Full Text] [Related]
6. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice.
Ajith TA; Harikumar KB; Thasna H; Sabu MC; Babitha NV
Clin Chim Acta; 2006 Apr; 366(1-2):322-8. PubMed ID: 16380106
[TBL] [Abstract][Full Text] [Related]
7. Influence of glutathione on the induction of chromosome aberrations, delay in cell cycle kinetics and cell cycle regulator proteins in irradiated mouse bone marrow cells.
Ray S; Chatterjee A
Int J Radiat Biol; 2007 May; 83(5):347-54. PubMed ID: 17457759
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
[TBL] [Abstract][Full Text] [Related]
9. Genotoxic, cytostatic, antineoplastic and apoptotic effects of newly synthesized antitumour steroidal esters.
Karapidaki I; Bakopoulou A; Papageorgiou A; Iakovidou Z; Mioglou E; Nikolaropoulos S; Mourelatos D; Lialiaris T
Mutat Res; 2009 Apr; 675(1-2):51-9. PubMed ID: 19386248
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity in vitro and preliminary antitumor activity in vivo of a novel organotin compound.
Barbieri F; Viale M; Sparatore F; Favre A; Cagnoli M; Bruzzo C; Novelli F; Alama A
Anticancer Res; 2000; 20(2A):977-80. PubMed ID: 10810384
[TBL] [Abstract][Full Text] [Related]
11. In vitro antiproliferative effects, toxicity profiles in vivo in mice and antitumour activity in tumour-bearing mice of five organotin compounds.
Gielen M; Willem R; Bouhdid A; De Vos D; Kuiper CM; Veerman G; Peters GJ
In Vivo; 1995; 9(1):59-63. PubMed ID: 7669950
[TBL] [Abstract][Full Text] [Related]
12. A novel class of achiral seco-analogs of CC-1065 and the duocarmycins: design, synthesis, DNA binding, and anticancer properties.
Kupchinsky S; Centioni S; Howard T; Trzupek J; Roller S; Carnahan V; Townes H; Purnell B; Price C; Handl H; Summerville K; Johnson K; Toth J; Hudson S; Kiakos K; Hartley JA; Lee M
Bioorg Med Chem; 2004 Dec; 12(23):6221-36. PubMed ID: 15519165
[TBL] [Abstract][Full Text] [Related]
13. [Studies on the antitumor activity of organotin compounds].
Peng J; Su HD
Yao Xue Xue Bao; 1994; 29(6):406-11. PubMed ID: 7992620
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of sister chromatid exchange induction and antitumor effects by homo-aza-steroidal esters of [p-[bis(2-chloroethyl)amino]phenyl]butyric acid.
Camoutsis C; Catsoulacos D; Karayiann V; Papageorgiou A; Mourelatos D; Mioglou E; Kritsi Z; Nikolaropoulos S
Cancer Detect Prev; 2001; 25(6):558-64. PubMed ID: 12132876
[TBL] [Abstract][Full Text] [Related]
15. SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 1: cellular pharmacology, in vitro and initial in vivo antitumor activity.
Hartley JA; Spanswick VJ; Brooks N; Clingen PH; McHugh PJ; Hochhauser D; Pedley RB; Kelland LR; Alley MC; Schultz R; Hollingshead MG; Schweikart KM; Tomaszewski JE; Sausville EA; Gregson SJ; Howard PW; Thurston DE
Cancer Res; 2004 Sep; 64(18):6693-9. PubMed ID: 15374986
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic activity of bis-[di-n-butyl(4-aminosalicylato)tin] oxide, NSC: 628561, bis-[diphenyl(4-aminosalicylato)tin] oxide, NSC: 628562, and some related compounds, against a series of human tumour cell lines.
Gielen M; Willem R
Anticancer Res; 1992; 12(1):257-68. PubMed ID: 1567174
[TBL] [Abstract][Full Text] [Related]
17. Modulation of mitomycin C-induced sister chromatid exchanges and cell cycle delay by buthionine sulfoximine and reduced glutathione in mouse bone marrow cells in vivo.
Giri SD; Chatterjee A
Mutat Res; 1998 Mar; 413(3):227-34. PubMed ID: 9651534
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antitumor activity of a new mixed-ligand complex di-n-butyl-(4-chlorobenzohydroxamato)tin(IV) chloride.
Li Y; Li Y; Niu X; Jie L; Shang X; Guo J; Li Q
J Inorg Biochem; 2008 Sep; 102(9):1731-5. PubMed ID: 18573534
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
[TBL] [Abstract][Full Text] [Related]
20. Toxicology and Carcinogenesis Studies of C.I. Pigment Red 3 (CAS No. 2425-85-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1992 Mar; 407():1-289. PubMed ID: 12621523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
